Molina Healthcare — Feb 5, 2026 release

Full Year Highlights • Fourth quarter 2025 GAAP loss per diluted share of $3.15 and adjusted loss per diluted share of $2.75 were burdened by approximately $2.00 of unfavorable retroactive revenue items. • Adjusted net income was $11.03 per diluted share for the full year 2025. • The Company issued its full year 2026 earnings guidance with expected premium revenue of approximately $42 billion and adjusted earnings of at least $5.00 per diluted share. The adjusted earnings guidance is burdened by $2.50 per share related to the implementation of a new Medicaid contract and underperformance in the traditional Medicare Advantage Part D (“MAPD”) product, which the Company will exit for 2027. • New store embedded earnings are now over $11.00 per diluted share. -MORE- Molina Healthcare, Inc. Reports Fourth Quarter and Year-End 2025 Financial Results Page 2 February 5, 2026 “We remain confident in our durable and sustaining operating platform,” said Joseph Zubretsky, President and Chief Executive Officer. “We believe that the imbalance between rates and trend marks 2026 as a trough year for Medicaid industry margins. Even at this low point in the cycle, we continue to produce positive pretax margins in Medicaid. We remain optimistic about the future earnings trajectory of the enterprise which includes anticipated rate restoration and future embedded earnings.” Premium Revenue Premium revenue was approximately $43.1 billion for the full year 2025, an increase of 11% year over year. The higher premium revenue reflects recent acquisitions, rate increases, and organic growth. Net